By Professor Sallie Pearson

Conference Papers

Morrow RL; Mintzes B; Souverein PC; De Bruin ML; Roughead EE; Lexchin J; Kemp-Casey A; Puil L; Sketris I; Mangin D; Hallgreen CE; Pearson S-A; Lopert R; Bero L; Ofori-Asenso R; Gnjidic D; Sarpatwari A; Dormuth CR, 2021, 'Influence of drug safety advisories on drug utilization: An international interrupted time series and meta-analysis study', in PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, WILEY, pp. 33 - 34, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000687807300068&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Gisev N; Pearson S-A; Dobbins T; Buizen L; Murphy T; Wilson A; Blyth F; Dunlop A; Larney S; Currow D; Mattick R; Degenhardt L, 2021, 'POPPY II cohort profile- a population-based linked cohort examining the course and outcomes of prescription opioid use in NSW, Australia, 2003-2018', in PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, WILEY, pp. 300 - 301, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000687807300611&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Varney B; Gilles MB; Havard A; Zoega H; Pearson S-A; Litchfield M, 2021, 'Prescription opioid use in Australian women of reproductive age from 2013 to 2020', in PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, WILEY, pp. 308 - 309, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000687807300627&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Mathieson S; Wertheimer G; Maher CG; Lin C; McLachlan AJ; Buchbinder R; Pearson SA; Underwood M, 2021, 'WHAT IS THE PREVALENCE OF OPIOID ANALGESIC USE IN PEOPLE WITH CHRONIC NON-CANCER PAIN: SYSTEMATIC REVIEW AND META-ANALYSIS OF OBSERVATIONAL STUDIES?', in INTERNAL MEDICINE JOURNAL, WILEY, pp. 15 - 16, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000651518500034&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Schaffer AL; Cairns R; Brown JA; Gisev N; Buckley NA; Pearson S-A, 2020, 'Changes in sales of over-the-counter and prescription medicines after rescheduling of codeine to a prescription-only medicine in Australia', in PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, WILEY, pp. 142 - 142, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000577640500298&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Costa J; Botha W; Braga Ceccato MDG; Pearson S; Goodall S; de Assis Acurcio F, 2020, 'Single versus multiple tablet regimens for first-line antiretroviral treatment of HIV: A real-world cost-effectiveness analysis using a patient cohort in Brazil', in JOURNAL OF THE INTERNATIONAL AIDS SOCIETY, JOHN WILEY & SONS LTD THE ATRIUM, SOUTHERN GATE, CHICHESTER PO19 8SQ, W …, pp. 162 - 162

Schaffer A; Zoega H; Tran DT; Buckley N; Pearson S; Havard A, 2019, 'Trajectories of antipsychotic use before and during pregnancy and related maternal and birth characteristics', in Pharmacoepidemiology and Drug Safety, Wiley, Philadelphia, USA, pp. 216 - 216, presented at International Conference on Pharmacoepidemiology, Philadelphia, USA, 24 August 2019 - 28 August 2019, http://dx.doi.org/10.1002/pds.4864

Daniels B; Kiely BE; Lord SJ; Houssami N; Pearson S-A, 2018, 'Abstract P2-12-01: Real-world use and outcomes of trastuzumab for HER2+ metastatic breast cancer in Australia: Analysis of the herceptin program, 2001-2015', in Cancer Research, American Association for Cancer Research (AACR), http://dx.doi.org/10.1158/1538-7445.sabcs17-p2-12-01

Raichand S; Pearson SA; Buckley NA; Havard A, 2017, 'Estimating the Average Daily Dose of Teratogenic Medicines Dispensed to Women of Child-Bearing Age', in PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, WILEY, pp. 417 - 417, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000437104300290&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Mallawaarachchi A; Ninomiya T; Laba T; Pearson S; Perkovic V; Jardine M, 2016, 'TRENDS IN HAEMOGLOBIN CONCENTRATION AND ERYTHROPOIESIS STIMULATING AGENT (ESA) USE IN THE AUSTRALIAN DIALYSIS POPULATION', in NEPHROLOGY, WILEY-BLACKWELL, pp. 119 - 120, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000383590600171&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Schaffer AL; Pearson S-A; Buckley NA, 2016, 'Does Concordance with Fixed-Dose Combination (FDC) Treatment Guidelines Improve Persistence? An Australian Population Based Cohort Study', in PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, WILEY-BLACKWELL, pp. 292 - 292, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000385483502132&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Blanch B; Degenhardt L; Gisev N; Dobbins TA; Larance B; Larney S; Pearson S-A, 2016, 'Prescription Opioid Access Patterns in Australia: A National Observational Cohort Study', in PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, WILEY-BLACKWELL, pp. 216 - 217, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000385483502006&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Blanch B; Buckley NA; Srasuebkul P; Litchfield M; Pearson S-A, 2015, 'Prescribed opioid use and potential misuse in Australia (2006 to 2013)', in PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, WILEY-BLACKWELL, pp. 157 - 158, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000369980200273&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Reekie J; Donovan B; Guy R; Mak D; Pearson S; Liu B, 2015, 'TRENDS IN CHLAMYDIA AND GONORRHOEA TESTING AND POSITIVITY IN WESTERN AUSTRALIAN WOMEN, 1998-2013', in SEXUALLY TRANSMITTED INFECTIONS, BMJ PUBLISHING GROUP, pp. A135 - A135, http://dx.doi.org/10.1136/sextrans-2015-052270.355

Rankin N; Shaw T; McGregor D; Butow P; White K; Young J; Phillips J; Pearson S; York S; Simes J; Jones R; Barnes D; Stone E, 2014, 'BUILDING AN IMPLEMENTATION SCIENCE PROGRAM IN LUNG CANCER CARE: RESULTS FROM SYDNEY CATALYST TRANSLATIONAL CANCER RESEARCH CENTRE', in ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, WILEY-BLACKWELL, pp. 85 - 85, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000345350900031&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Shaw T; Rankin N; McGregor D; White K; Phillips J; Butow P; Young J; Trevena L; Pearson S; York S, 2014, 'A SYSTEMATIC APPROACH TO CLOSING EVIDENCE GAPS IN CANCER CARE', in ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, WILEY-BLACKWELL, pp. 22 - 22, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000344745100048&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Pearson S-A, 2014, 'BIG DATA LINKAGES: THE MAGIC BULLET FOR CANCER HEALTH SERVICE RESEARCH?', in ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, WILEY-BLACKWELL, pp. 18 - 18, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000344745100036&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Reeve R; Srasuebkul P; Pearson S; Viney R; Haas M, 2014, 'COSTS OF CANCER CARE AT THE END OF LIFE', in ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, WILEY-BLACKWELL, pp. 39 - 39, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000344745100106&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Pace J; Pearson S; Lipworth W, 2014, 'LEGITIMACY OF FUNDING DECISIONS FOR CANCER MEDICINES: A THEMATIC ANALYSIS OF STAKEHOLDER PERSPECTIVES', in ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, WILEY-BLACKWELL, pp. 39 - 39, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000344745100105&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Srasuebkul P; Reeve R; Viney R; Haas M; Pearson S, 2014, 'RESOURCE USE IN THE LAST 180 DAYS OF LIFE IN THE ELDERLY DECENDENTS', in ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, WILEY-BLACKWELL, pp. 39 - +, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000344745100107&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Harris C; Daniels B; Ward R; Pearson S-A, 2014, 'Do Pharmaceutical Claims Accurately Reflect Oncology Prescribing Practice: Evidence from an Australian HER2+Early Breast Cancer Cohort (HER2EBC)', in PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, WILEY-BLACKWELL, pp. 465 - 466, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000342763600858&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Harris C; Pearson S-A; Daniels B; Ward R, 2014, 'HER2 Positive Early Breast Cancer (HER2EBC): An Australian Patterns of Care Study', in PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, WILEY-BLACKWELL, pp. 468 - 468, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000342763600863&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Gnjidic D; Pearson S-A; Hilmer S; Basilakis J; Blyth F; Banks E, 2014, 'Manual Versus Automated Coding of Free-Text Self-Reported Drug Use in the 45 and Up Study: A Validation Study', in PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, WILEY-BLACKWELL, pp. 143 - 144, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000342763600270&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Leung C; Hilmer S; Pearson S-A; Gnjidic D, 2014, 'Temporal Changes in Polypharmacy, Hyperpolypharmacy and Exposure to Anticholinergic and Sedative Drugs: A Five-Year Study of Community-Dwelling Older Men', in PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, WILEY-BLACKWELL, pp. 119 - 119, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000342763600221&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Blanch B; Pearson SA; Haber PS, 2014, 'An overview of the patterns of prescription opioid use, costs and related harms in Australia', in British Journal of Clinical Pharmacology, pp. 1159 - 1166, http://dx.doi.org/10.1111/bcp.12446

Harris CA; Ward RL; Daniels B; Pearson S, 2013, 'Do pharmaceutical claims accurately reflect oncology prescribing practice? Evidence from an Australian HER2+early breast cancer cohort ( HER2EBC).', in JOURNAL OF CLINICAL ONCOLOGY, AMER SOC CLINICAL ONCOLOGY, CA, San Diego, presented at ASCO's Quality Care Symposium, CA, San Diego, 01 November 2013 - 02 November 2013, http://dx.doi.org/10.1200/jco.2013.31.31_suppl.100

Harris CA; Pearson S; Daniels B; Srasuebkul P; Ward RL, 2013, 'HER2-positive early breast cancer (HER2EBC): An Australian pattern of care study', in JOURNAL OF CLINICAL ONCOLOGY, AMER SOC CLINICAL ONCOLOGY, CA, San Diego, presented at ASCO's Quality Care Symposium, CA, San Diego, 01 November 2013 - 02 November 2013, http://dx.doi.org/10.1200/jco.2013.31.31_suppl.101

Langton JM; Blanch B; Drew A; Haas M; Ingham JM; Pearson S, 2013, 'Resource utilization, costs, and quality of end-of-life cancer care: A systematic review of retrospective cohort studies based on routinely collected data (1990-2011)', in JOURNAL OF CLINICAL ONCOLOGY, AMER SOC CLINICAL ONCOLOGY, CA, San Diego, presented at ASCO's Quality Care Symposium, CA, San Diego, 01 November 2013 - 02 November 2013, http://dx.doi.org/10.1200/jco.2013.31.31_suppl.111

Ganda K; Seibel M; Schaffer A; Pearson S, 2013, 'Adherence to Oral Bisphosphonate Therapy in a Fracture Liaison Service: A Randomised Controlled Trial', in JOURNAL OF BONE AND MINERAL RESEARCH, WILEY-BLACKWELL, MD, Baltimore, presented at Annual Meeting of the American-Society-for-Bone-and-Mineral-Research, MD, Baltimore, 04 October 2013 - 07 October 2013, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000332035804007&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Pearson S-A; Abrahamowicz M; Srasuebkul P; Buckley N, 2013, 'Antidepressant Treatment (ADT) Following a Cancer Diagnosis: Investigation in a Cohort of Older Patients', in PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, WILEY-BLACKWELL, pp. 199 - 199, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000334876100384&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Pearson S-A; Srasuebkul P; Lu C; Dobbins T; Ward R, 2011, 'The Impact of Evidence-Based Subsidy Restrictions on Lapatinib Use and Outcomes', in PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, WILEY-BLACKWELL, pp. S77 - S77, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000294946600172&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Stavrou EP; Lu CY; Pearson S-A, 2011, 'The Role of Comorbidity in the Uptake of Chemotherapy and Cancer Survival', in PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, WILEY-BLACKWELL, pp. S279 - S280, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000294946600618&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Pearson S; Srasuebkul P; Harris C; Ward RL; Dobbins TA; Harris C, 2010, 'Trastuzumab treatment outcomes according to concomitant chemotheray regimen: Overall survival of HER2+ metastatic breast cancer patients', in Storm BL; Hasford J; Hennessy S; Park BJ (eds.), Pharmacoepidemiology and Drug Safety, John Wiley & Sons Ltd, Chichester, W Sussex, England, pp. S187 - S187, presented at Pharmacoepidemiology & Therapeutic Risk Management, Brighton, UK, 19 August 2010 - 22 August 2010, http://dx.doi.org/10.1002/pds

Pearson S; Chin M; Ward RL, 2009, 'The Financially Tolerable Dose: A New Concept in Cancer Trial Design', in Storm BL; Hasford J; Hennessy S; Park BJ (eds.), Pharmacoepidemiology and Drug Safety, John Wiley & Sons Ltd, Chichester, W Sussex, England, pp. S173 - S174

Pearson S; Ringland C; Ward RL, 2008, 'Off-label trastuzumab use in Australia: Evidence from the national Herceptin Program for HER-2 positive metastatic breast cancer', in Storm BL; Hasford J; Hennessy S; Park BJ (eds.), Pharmacoepidemiology and Drug Safety, John Wiley & Sons Ltd, Chichester, W Sussex, England, pp. 66 - 66, presented at Pharmacoepidemiology and Drug Safety

Ringland C; Pearson S; Ward RL, 2008, 'Survival of women treated with trastuzumab for HER-2-positive metastatic breast cancer: Estimating outcomes in clinical practice using administrative data', in Storm BL; Hasford J; Hennessy S; Park BJ (eds.), Pharmacoepidemiology and Drug Safety, John Wiley & Sons Ltd, Chichester, W Sussex, England, pp. 436 - 437, presented at Pharmacoepidemiology and Drug Safety

Conference Posters

Gisev N; Degenhardt L; Buckley N; Larney S; Dobbins T; Pearson S, 2017, 'To what extent do data from pharmaceutical claims under-estimate opioid analgesic utilisation in Australia?', Vol. 26, pp. 106 - 106, presented at National Drug and Alcohol Research Centre 2017 Annual Symposium, 03 October 2017 - 04 October 2017

Schaffer AL; buckley N; cairns R; pearson S, 2016, 'Up-Scheduling of Alprazolam to a “Controlled Drug”: Interrupted Time Series Analysis of Its Impact on Benzodiazepine (BZD) Prescribing, Dispensing and Poisonings in Australia.', Dublin, Ireland, Vol. 25, pp. 346 - 347, presented at 32nd International Conference on Pharmacoepidemiology & Therapeutic Risk Management, Dublin, Ireland, 25 August 2016 - 28 August 2016, http://dx.doi.org/10.1002/pds.4070

Ringland C; Pearson S-A; Ward RL, 2008, 'Survival of women treated with trastuzumab for HER-2-positive metastatic breast cancer: Estimating outcomes in clinical practice using administrative data', Vol. 17, pp. S191 - S192, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000258420100436&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Conference Presentations

Bharat C; Gisev N; Hopkins R; Pearson SA; Gillies M; Dobbins T; Larney S; Blythe F; Degenhardt L, 2024, 'Development of opioid use disorder following treatment with opioid analgesics for non-cancer pain relief: an Australian state-wide nested case-control study', presented at 2024 NDARC Annual Research Symposium, Wesley Conference Centre, Sydney NSW, 20 September 2024, https://www.youtube.com/watch?v=SwVO9ONBuE8&t=5295s

Robijn A; Tran DT; Cohen JM; Donald S; Cesta CE; Furu K; Parkin L; Pearson SA; Reutfors J; Zoega H; Zwar N; Havard A, 2024, 'Effectiveness of prescription smoking cessation pharmacotherapies during pregnancy: a multi-national study', presented at 2024 NDARC Annual Research Symposium, Wesley Conference Centre, Sydney NSW, 20 September 2024

Tran D; Varney B; Jones N; Bharat C; Brett J; Oei J; Pearson SA; Degenhardt L; Havard A, 2024, 'Trends in the use of opioid agonist treatment for opioid dependence in pregnancy', presented at 2024 NDARC Annual Research Symposium, Wesley Conference Centre, Sydney NSW, 20 September 2024, https://www.youtube.com/watch?v=Cph4ZrfKiMw&t=1850s

Varney B; Bharat C; Brett J; Degenhardt L; Jones N; Oei J; Pearson SA; Havard A; Tran DT, 2024, 'Use of opioid agonist therapy in pregnancy: Timing of initiation and treatment retention', presented at 2024 NDARC Annual Research Symposium, Wesley Conference Centre, Sydney NSW, 20 September 2024, https://www.youtube.com/watch?v=Cph4ZrfKiMw&t=2664s

Schaffer A; Nassar N; Bruno C; Buckley N; Cairns R; Litchfield M; Paget S; Zoega H; Pearson S, 2021, 'Prescribed Medicine Use in a Nationwide Sample of Australian Children: Extent of Off-Label Use', presented at International Conference on Pharmacoepidemiology and Therapeutic Risk Management, Virtual, 23 August 2021 - 25 August 2021

Schaffer A; Brett J; Buckley N; Pearson S, 2021, 'Trajectories of Pregabalin Use and Their Association with Longitudinal Changes in Opioid and Benzodiazepine Daily Dose', presented at International Conference on Pharmacoepidemiology and Therapeutic Risk Management, Virtual, 23 August 2021 - 25 August 2021

Schaffer A; Cairns R; Brown J; Gisev N; Buckley N; Pearson S, 2020, 'Changes in sales of over‐the‐counter and prescription medicines after rescheduling of codeine to a prescription‐only medicine in Australia', presented at International Conference on Pharmacoepidemiology and Therapeutic Risk Management

Daniels B, 2019, 'Identifying incident cancer cases in medicine dispensing claims: A validation study using Australia’s Pharmaceutical Benefits Scheme (PBS) data', presented at Asian Conference on Pharmacoepidemiology & Therapeutic Risk Management, 11 October 2019 - 13 October 2019

Schaffer A; Buckley N; Pearson S, 2019, 'Unintended Consequences of a National Policy Intervention to Curb Inappropriate Alprazolam Prescribing in Australia', presented at International Conference on Pharmacoepidemiology and Drug Safety, Philadelphia, USA, 24 August 2019 - 28 August 2019, http://dx.doi.org/10.1002/pds.4864

Daniels B; Pearson S, 2019, 'Understanding Treatment Pathways for HER2-Positive Metastatic Breast Cancer (HER2+MBC) Patients: Analysis Using Group-Based Trajectory Models (GBTM)', presented at International Conference on Pharmacoepidemiology & Therapeutic Risk Management, Prague, Czechia, 24 August 2019 - 26 August 2019

Daniels B; Pearson S, 2017, 'Real-world use and outcomes of trastuzumab for HER2+ metastatic breast cancer in Australia: Analysis of the Herceptin Program, 2001 – 2015', presented at San Antonio Breast Cancer Symposium, San Antonio, TX, USA, 06 December 2017 - 10 December 2017

Back to profile page